Results 71 to 80 of about 4,947,726 (309)

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Biotechnological sovereignty is not a mere nationalist concept, it is a necessity for Colombia and Latin America [PDF]

open access: yesCadernos de Saúde Pública
: During the pandemic, Latin American countries suffered the collapse of their health systems. This was caused by the high demand for care of patients infected with SARS-CoV-2, which was added to the care of patients with other diseases.
Camilo Guzman   +4 more
doaj   +1 more source

Future strategy : Action Programme on Essential Drugs

open access: yes, 1993
ONLINEWHO/DAP/94.4.
WHO Action Programme on Essential Drugs
core  

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

open access: yesFEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani   +3 more
wiley   +1 more source

Profile of continuous use drugs prescribed in primary health care and presence in list of essential drugs

open access: yesRevista de Ciências Farmacêuticas Básica e Aplicada, 2021
Objectives: To evaluate the profile of the drugs for continuous use prescribed in Primary Health Care (PHC) in Santa Rosa / RS and to identify presence in the official lists of essential drugs. Methods: Cross-sectional, analytical and quantitative study,
Paula Lorenzoni Nunes   +5 more
doaj  

Differential pricing and financing of essential drugs : a WHO/WTO secretariat workshop

open access: yes, 2001
Workshop jointly convened by the World Health Organization and World Trade Organization secretariats, the Norwegian Foreign Affairs Ministry, the Global Health Council, 8-11 April 2001, Hosbjor, NorwayCover title: Differential pricing and financing of ...
Workshop on Differential Pricing and Financing of Essential Drugs (2001: Hosbjor, Norway)
core  

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

open access: yesFEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi   +6 more
wiley   +1 more source

Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal

open access: yesBMC Health Services Research, 2017
Background The successful control of cardiovascular diseases at the lowest possible cost requires the use of the most effective and affordable medicines.
Helena Gama   +5 more
doaj   +1 more source

National Drugs Advisory Board annual report, 1990.

open access: yes, 1990
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No.163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

Home - About - Disclaimer - Privacy